[Advances in the study of nitric oxide-donating drugs]
- PMID: 21355319
[Advances in the study of nitric oxide-donating drugs]
Abstract
Nitric oxide (NO) as a messenger and/or effector plays important roles in vivo. The decreased availability of NO or dysfunction in NO signaling has often been implicated in the development and progression of diseases, and design and research of NO-donating drugs has become one of the important strategies in drug discovery. In connection with authors' scientific practice, this article reviews the recent advances in the research of NO-donating drugs.
Similar articles
-
New nitric oxide donating 1,2,4-triazole/oxime hybrids: synthesis, investigation of anti-inflammatory, ulceroginic liability and antiproliferative activities.Bioorg Med Chem. 2013 Jul 1;21(13):3839-49. doi: 10.1016/j.bmc.2013.04.022. Epub 2013 Apr 18. Bioorg Med Chem. 2013. PMID: 23665142
-
Nitric-oxide-donating NSAIDs as agents for cancer prevention.Trends Mol Med. 2004 Jul;10(7):324-30. doi: 10.1016/j.molmed.2004.05.004. Trends Mol Med. 2004. PMID: 15242680 Review.
-
New nitric oxide-donating drugs for the treatment of airway diseases.Curr Opin Investig Drugs. 2004 May;5(5):537-41. Curr Opin Investig Drugs. 2004. PMID: 15202728 Review.
-
Nitrates and NO-NSAIDs in cancer chemoprevention and therapy: in vitro evidence querying the NO donor functionality.Nitric Oxide. 2008 Sep;19(2):115-24. doi: 10.1016/j.niox.2008.04.013. Epub 2008 Apr 23. Nitric Oxide. 2008. PMID: 18485921 Free PMC article.
-
[Targeting of nitric oxide-donor and related drugs].Yao Xue Xue Bao. 2006 Jun;41(6):481-6. Yao Xue Xue Bao. 2006. PMID: 16927819 Review. Chinese. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources